Future Prospects of Global Laboratory Proficiency Testing Market

A central venous catheter, also known as a central line or a central venous line, is a type of central venous catheter. It is a flexible tube that is put into a vein beneath the right side of the collarbone and led to the superior vena cava, a big vein that leads to the heart. Intravenous liquids, blood transfusions, and chemotherapy medications are all administered through a central venous catheter.
In 2011, the Centers for Disease Control and Prevention
(CDC) released guidelines to help prevent intravascular catheter-related
infections, which were updated in 2017.
The Central
Venous Catheter market is predicted to develop due to factors such as
an increase in the prevalence of cardiovascular illnesses such as
atherosclerosis, coronary artery disease, myocardial infarction, and
cardiomyopathy, increased awareness of sophisticated technologies, and an
increase in the geriatric population. In addition, the market is growing due to
an increase in demand for antimicrobial catheters. In rising markets such as
Africa, Asia-Pacific, and the Middle East, however, high product costs are
projected to constrain the market. During the projection period, R&D in the
sector of surgical equipment is expected to provide new opportunities.
Product, property, design, composition, end-user, and
geography are all used to segment the central
venous catheter market. The market is divided into tunnelled and
non-tunneled catheters based on product. The market is divided into
antimicrobial and non-antimicrobial catheters based on their properties. Based
on product, the market is split into tunnelled and non-tunneled catheters.
Based on its qualities, the market is classified into antimicrobial and
non-antimicrobial catheters. The market is divided into hospitals, ambulatory
surgical centres, clinics, and others based on the end-user. It was studied
across North America, Europe, Asia-Pacific, and Latin America and the
Caribbean.
Furthermore, the increased prevalence of chronic diseases
such as cancer, cardiovascular diseases, and chronic kidney disease (CKD) is
driving the demand for treatment and care using central venous catheterization,
which is likely to fuel market growth. According to WHO data, cancer was the
second-leading cause of death globally in February 2018, with roughly 18.1
million new cases and 9.6 million deaths reported. According to the same
source, cancer kills roughly 70% of people in low- and middle-income nations,
and cancer kills one out of every six people worldwide.
Comments
Post a Comment